Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-07-01Clinical Trial Update: Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus [Phase 2]
Open-label Phase 2 extension study evaluating Neramexane for congenital and acquired nystagmus has been terminated. The update summarizes sa…
-
CLINICAL_TRIALS research · 2010-06-28Clinical Trial Update: Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct
A clinical trial update describing a study evaluating neural loss in multiple sclerosis and neuromyelitis optica using high-resolution optic…
-
CLINICAL_TRIALS research · 2010-06-24Clinical Trial Update: Validation of an Obstacle Course Used in Patients With Muscle Tightness
A clinical trial update from the Kessler Foundation on validating an obstacle course used to assess muscle tightness. The study includes par…
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
Completed open-label tolerability and safety monitoring study of Novantrone (mitoxantrone) in a selected cohort of patients with multiple sc…
-
CLINICAL_TRIALS withdrawal · 2010-06-03Clinical Trial Update: Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment [Phase 1]
A Phase 1 trial evaluating nasal dexamethasone for multiple sclerosis was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: Rebif® Pregnancy Registry
The Rebif pregnancy registry for multiple sclerosis has completed. Results were posted on 2010-06-02.
-
FDA approval · 2010-04-27FDA Approved: BACLOFEN — Supplemental Application (Northstar RxLLC)
The FDA approved a supplemental application for baclofen submitted by Northstar RxLLC. Baclofen is used to reduce muscle spasticity in condi…
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: FolateScan in Autoimmune Disease [Phase 2]
A Phase 2 clinical trial of FolateScan in autoimmune diseases has completed, including rheumatoid arthritis, osteoarthritis, multiple sclero…
-
CLINICAL_TRIALS trial_result · 2010-03-08Clinical Trial Update: Avonex 15 Year Long Term Follow-up Study
This document provides a long-term (15-year) follow-up update for Avonex (interferon beta-1a) in multiple sclerosis, with the trial status l…
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
A completed clinical trial evaluating ATP expression in lymphocytes of individuals with multiple sclerosis using the ImmuKnow assay.
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis [Phase 3]
An open-label Phase 3 study evaluating the effect, safety and tolerability of Betaferon 250 µg in Chinese-origin patients with multiple scle…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) [Phase 4]
Phase 4 clinical trial evaluating glatiramer acetate in clinically isolated syndrome or early relapsing-remitting multiple sclerosis; uses o…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Climate Influence on Physiotherapy in Multiple Sclerosis [NA]
A completed clinical trial evaluating whether climate conditions influence the outcomes of physiotherapy in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Biogen-sponsored clinical trial has completed comparing Avonex and Rebif to determine if they work comparably in relapsing multiple sclerosi…
-
FDA approval · 2010-01-22FDA Approved: AMPYRA — Original Application (Merz Pharmaceuticals, LLC)
FDA approved AMPYRA (dalfampridine) through its Original Application submitted by Merz Pharmaceuticals for improving walking in adults with …
-
FDA approval · 2010-01-21FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved a supplemental application for TYSABRI (Natalizumab) from Biogen Inc. The approval updates the drug's label and indications…
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Levetiracetam in Central Pain in Multiple Sclerosis(MS) [Phase 4]
A Phase 4 clinical trial evaluating levetiracetam for central pain in people with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: FOCUS Fatigue Outcome in Copaxone USers [Phase 4]
A Phase 4 clinical trial update reports on fatigue outcomes in people with multiple sclerosis treated with Copaxone.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis [Phase 2]
Phase 2 safety and efficacy study of CNTO1275 in patients with multiple sclerosis has completed, with results posted. The sponsor was Centoc…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
An update on an exploratory study evaluating the reparative and regenerative potential of alemtuzumab in relapsing-remitting multiple sclero…
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: BEYOND Pilot Study [Phase 2]
The BEYOND Pilot Study, a Phase 2 trial sponsored by Bayer, has completed in relapsing-remitting multiple sclerosis.
-
FDA approval · 2009-10-26FDA Approved: KESIMPTA — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved Kesimpta (ofatumumab) under an original Biologics License Application from Novartis for the treatment of relapsing forms of…
-
CLINICAL_TRIALS research · 2009-09-29Clinical Trial Update: Characteristic Study on Chinese Patients With Multiple Sclerosis [NA]
A characterization study describing Chinese patients with multiple sclerosis conducted by Sun Yat-sen University.
-
FDA approval · 2009-09-18FDA Approved: BACLOFEN — Original Application (Northstar RxLLC)
FDA approved the original ANDA for generic baclofen from Northstar RxLLC. This approval authorizes the generic product for treating spastici…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS) [EARLY_Phase 1]
A multicenter early-phase study assessed whether plasma exchange can accelerate natalizumab clearance in people with relapsing forms of mult…